
Cadpride M 2mg/500mg Tablet SR
Marketer
Caddes Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Cadpride M 2mg/500mg Tablet SR
Diabetic patients, adult type 2 specifically, may find relief with the dual-action medication, Cadpride M 2mg/500mg SR tablets. This anti-diabetic formulation regulates blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Cadpride M is just one component of comprehensive diabetes management, which also necessitates dietary adjustments, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, or tremors. Regular meals and readily available fast-acting glucose (sugary snacks or juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain is possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your physician prior to use during pregnancy or lactation. Regular blood glucose checks, along with blood cell and liver function tests as advised, are necessary for ongoing monitoring.
Primary Ingredients of Cadpride M 2mg/500mg Tablet SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Cadpride M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Cadpride M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cadpride M 2mg/500mg SR Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.
Common Side effects of Cadpride M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Cadpride M 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cadpride M 2mg/500mg Extended-Release tablets should be administered with a meal.
How Cadpride M 2mg/500mg Tablet SR works:
Cadpride M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Cadpride M 2mg/500mg SR tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Cadpride M 2mg/500mg SR tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks before prescribing. Seek medical advice.
Breast feedingUNSAFE
Sustained-release Cadpride M tablets (2mg/500mg) are contraindicated during lactation due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with kidney impairment, Cadpride M 2mg/500mg SR tablets require careful administration and may necessitate dosage modification. Patients with severe kidney disease should not use Cadpride M 2mg/500mg SR tablets. Physician consultation is essential. Routine monitoring of kidney function is recommended during treatment with this medication.
LiverCAUTION
Individuals with liver impairment should use Cadpride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, Cadpride M 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Cadpride M 2mg/500mg Tablet SR :
Should you forget a Cadpride M 2mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cadpride M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
